Hu Y, Yang R, Ni S, Song Z
Front Immunol. 2025; 15:1485053.
PMID: 39995821
PMC: 11847827.
DOI: 10.3389/fimmu.2024.1485053.
Smith G, Lee M, Jennings E, James J
Discov Immunol. 2025; 4(1):kyae019.
PMID: 39959909
PMC: 11829120.
DOI: 10.1093/discim/kyae019.
Oyama R, Nabeshima A, Endo M, Novikov A, Fujiwara T, Phelip C
BJC Rep. 2025; 3(1):5.
PMID: 39870886
PMC: 11772650.
DOI: 10.1038/s44276-024-00120-3.
Skalickova M, Hadrava Vanova K, Uher O, Leischner Fialova J, Petrlakova K, Masarik M
Front Immunol. 2025; 15:1479483.
PMID: 39850897
PMC: 11754201.
DOI: 10.3389/fimmu.2024.1479483.
Devaraja K, Singh M, Sharan K, Aggarwal S
Biomedicines. 2025; 12(12.
PMID: 39767654
PMC: 11726767.
DOI: 10.3390/biomedicines12122746.
Research advancements in nanoparticles and cell-based drug delivery systems for the targeted killing of cancer cells.
Abdessalem M, Adham S
Oncol Res. 2024; 33(1):27-44.
PMID: 39735681
PMC: 11671623.
DOI: 10.32604/or.2024.056955.
Virus nanotechnology for intratumoural immunotherapy.
Omole A, Zhao Z, Chang-Liao S, de Oliveira J, Boone C, Sutorus L
Nat Rev Bioeng. 2024; 2(11):916-929.
PMID: 39698315
PMC: 11655125.
DOI: 10.1038/s44222-024-00231-z.
Balancing Tumor Immunotherapy and Immune-Related Adverse Events: Unveiling the Key Regulators.
Huang J, Xiong L, Tang S, Zhao J, Zuo L
Int J Mol Sci. 2024; 25(20).
PMID: 39456702
PMC: 11507008.
DOI: 10.3390/ijms252010919.
[F]F-AraG Uptake in Vertebral Bone Marrow May Predict Survival in Patients with Non-Small Cell Lung Cancer Treated with Anti-PD-(L)1 Immunotherapy.
Levi J, Das M, Vasanawala M, Behl D, Pomper M, Forde P
J Nucl Med. 2024; 65(12):1869-1875.
PMID: 39448270
PMC: 11619592.
DOI: 10.2967/jnumed.124.268253.
William Coley: The Pioneer and the Father of Immunotherapy.
Munir M, Cheema A, Ogedegbe O, Aslam M, Kim S
Cureus. 2024; 16(9):e69113.
PMID: 39391466
PMC: 11466495.
DOI: 10.7759/cureus.69113.
Bactofection, Bacterial-Mediated Vaccination, and Cancer Therapy: Current Applications and Future Perspectives.
Renteria-Flores F, Garcia-Chagollan M, Jave-Suarez L
Vaccines (Basel). 2024; 12(9).
PMID: 39340000
PMC: 11435753.
DOI: 10.3390/vaccines12090968.
Towards Understanding Tumour Colonisation by Probiotic Bacterium Nissle 1917.
Radford G, Vrbanac L, de Nys R, Worthley D, Wright J, Hasty J
Cancers (Basel). 2024; 16(17).
PMID: 39272829
PMC: 11394440.
DOI: 10.3390/cancers16172971.
New strategies in soft tissue sarcoma treatment.
Spalato-Ceruso M, El Ghazzi N, Italiano A
J Hematol Oncol. 2024; 17(1):76.
PMID: 39218932
PMC: 11368005.
DOI: 10.1186/s13045-024-01580-3.
Cracking the Codes behind Cancer Cells' Immune Evasion.
Mundhara N, Sadhukhan P
Int J Mol Sci. 2024; 25(16).
PMID: 39201585
PMC: 11354234.
DOI: 10.3390/ijms25168899.
Cancer immunotherapy and its facilitation by nanomedicine.
Sui C, Wu H, Li X, Wang Y, Wei J, Yu J
Biomark Res. 2024; 12(1):77.
PMID: 39097732
PMC: 11297660.
DOI: 10.1186/s40364-024-00625-6.
Immune Regulation and Immune Therapy in Melanoma: Review with Emphasis on CD155 Signalling.
Wu L, Park S, Jakobsson H, Shackleton M, Moller A
Cancers (Basel). 2024; 16(11).
PMID: 38893071
PMC: 11171058.
DOI: 10.3390/cancers16111950.
Recent Insights into the Molecular Mechanisms of the Toll-like Receptor Response to Influenza Virus Infection.
Kayesh M, Kohara M, Tsukiyama-Kohara K
Int J Mol Sci. 2024; 25(11).
PMID: 38892096
PMC: 11172706.
DOI: 10.3390/ijms25115909.
Trends in the use of immunotherapy to treat soft tissue sarcoma.
Iwai Y, Baldwin X, Feeney T, Agala C, Yanagihara T, Stein J
Am J Surg. 2024; 236:115794.
PMID: 38879356
PMC: 11392640.
DOI: 10.1016/j.amjsurg.2024.115794.
Vaccination with DC-SIGN-Targeting αGC Liposomes Leads to Tumor Control, Irrespective of Suboptimally Activated T-Cells.
de Haas A, Stolk D, Schetters S, Goossens-Kruijssen L, Keuning E, Ambrosini M
Pharmaceutics. 2024; 16(5).
PMID: 38794243
PMC: 11124829.
DOI: 10.3390/pharmaceutics16050581.
Sono-activatable engineered bacteria for antitumor therapy.
Wang Y, Yan F
Cell Rep Med. 2024; 5(5):101562.
PMID: 38776871
PMC: 11148798.
DOI: 10.1016/j.xcrm.2024.101562.
